Michel Zelaquett/LinkedIn
Apr 23, 2026, 07:33
Michel Zelaquett: Ultra-Minimally Invasive Treatment for Uterine Fibroids
Michel Zelaquett, Founder and Director at Centro de Mioma, shared a post on LinkedIn:
“Ultra-Minimally Invasive Treatment for Uterine Fibroids
No incisions. No scars. Minimal invasion, maximum precision.
Cutting-edge technology in service of uterine preservation and fertility — because every woman deserves access to treatments that respect her body and her future.
Proud to be part of a dedicated team pushing the boundaries of modern gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 29, 2026, 01:03Seeking a Second Opinion Is Not Being Difficult, It Is a Valid Part of Informed Care – PCOS Awareness Association
-
Jul 29, 2026, 00:57Szabo Gabor: IOTA Day 2026 Advancing Ultrasound in Gynaecological Oncology
-
Jul 29, 2026, 00:55Islam Badr: A Simple Approach to Fetal Heart Screening
-
Jul 29, 2026, 00:50Hardeep Singh: Understanding the Global IVF Travel Landscape
-
Jul 29, 2026, 00:48Asma Khatun: Shaping the Future of Women’s Healthcare at GFWH 2026
-
Jul 29, 2026, 00:43Shaping the Future of Reproductive Medicine at ASRM Innovate – ASRM
-
Jul 29, 2026, 00:37George Condous: Gratitude Makes Every Achievement Greater!
-
Jul 29, 2026, 00:35As AMH Falls, Progesterone May Rise Earlier in Ovarian Stimulation! – Fertility Plus
-
Jul 29, 2026, 00:33An Easy Method for Systematic Fetal Cardiac Screening – ISUOG